Toxic epidermal necrolysis (Lyell’s syndrome) in a patient with HIV infection

Abstract

Lyell’s syndrome, or toxic epidermal necrolysis, is a skin disorder characterized by extensive exfoliation of the epidermis. The prognosis for this disease is poor due to damage to the visceral organs, electrolyte disturbances and the risk of infection. The article describes a clinical case of Lyell’s syndrome in an HIV-infected patient who was first prescribed ART in combination with valganciclovir. The diagnosis was made on the basis of characteristic clinical manifestations and the exclusion of another similar pathology. On the background of the therapy, the rash regressed, the areas of damaged skin became epithelialized, and the body temperature returned to normal. A differential diagnosis was made with measles, Stevens-Johnson syndrome, staphylococcal infection. Against the background of the therapy, the patient’s condition was positive.

Keywords

Lyell’s syndrome / HIV infection / antiretroviral therapy

References

[1] Esedov EM, Akhmedova FD, Akbieva DS. Toxic epidermal necrolysis in the practice of a family doctor. General practitioner reference book. 2020;(1):61–67. (In Russ). doi: 10.33920/med-10-2001-09

[2] Эседов Э.М., Ахмедова Ф.Д., Акбиева Д.С. Токсический эпидермальный некролиз в практике семейного врача // Справочник врача общей практики. 2020. № 1. С. 61–67. doi: 10.33920/med-10-2001-09

[3] Koudelka EN, Shakhmanov DM, Sobolev AF, et al. Toxic epidermal necrolysis (Lyell’s syndrome). Journal of Infectology. 2017;9(4):144–152. (In Russ). doi: 10.22625/2072-6732-2017-9-4-144-152

[4] Куделка Е.Н., Шахманов Д.М., Соболев А.Ф. и др. Токсический эпидермальный некролиз (синдром Лайелла) // Журнал инфектологии. 2017. Т. 9, № 4. С. 144–152. doi: 10.22625/2072-6732-2017-9-4-144-152

[5] Tezyaeva SA, Mlynnik RA, Degtyareva SF, et al. Lyell’s syndrome as a rare complication of drug therapy. Medial Magazine. 2015;(2):42–45. (In Russ).

[6] Тезяева С.А., Млинник Р.А., Дегтярева С.Ф. и др. Синдром Лайелла как редкое осложнение медикаментозной терапии // Журнал Медиаль. 2015. № 2. С. 42–45.

[7] Hoffmann K, Rokstro YuK, ed. HIV 2014/2015. Medizin Fokus. Hamburg, Bonn; 2014. 924 р. (In Russ).

[8] Хоффманн К., Рокштро Ю.К., ред. ВИЧ 2014/2015. Medizin Fokus. Гамбург, Бонн, 2014. 924 с.

[9] Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147–176. doi: 10.1007/s12016-017-8654-z

[10] Lerch M., Mainetti C., Terziroli Beretta-Piccoli B., Harr T. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis // Clin Rev Allergy Immunol. 2018. Vol. 54, N 1. Р. 147–176. doi: 10.1007/s12016-017-8654-z

[11] Tseng J, Maurer T, Mutizwa MM. HIV-associated toxic epidermal necrolysis at San Francisco General Hospital. J Int Assoc Provid AIDS Care. 2017;16(1):37–41. doi: 10.1177/2325957415614651

[12] Tseng J., Maurer T., Mutizwa M.M. HIV-associated toxic epidermal necrolysis at San Francisco General Hospital // J Int Assoc Provid AIDS Care. 2017. Vol. 16, N 1. Р. 37–41. doi: 10.1177/2325957415614651

[13] French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorrizo JL, Schaffer JV, editors. Dermatology 3rd edition. New York: Elsevier; 2013. Р. 319–333. doi: 10.1002/9781444317633.ch76

[14] French L.E., Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia J.L., Jorrizo J.L., Schaffer J.V., editors. Dermatology 3rd edition. New York: Elsevier; 2013. Р. 319–333. doi: 10.1002/9781444317633.ch76.

[15] Chen P, Lin JJ, Lu CS. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364(12):1126–1133. doi: 10.1056/NEJMoa1009717

[16] Chen P., Lin J.J., Lu C.S. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan // N Engl J Med. 2011. Vol. 364, N 12. Р. 1126–1133. doi: 10.1056/NEJMoa1009717

[17] Hung SI, Chung WH, Liou LB. HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134–4139. doi: 10.1073/pnas.0409500102

[18] Hung S.I., Chung W.H., Liou L.B. HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol // Proc Natl Acad Sci USA. 2005. Vol. 102, N 11. Р. 4134–4139. doi: 10.1073/pnas.0409500102

[19] Cartotto R, Mayich M, Nickerson D, Gomez M. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res. 2008;29(1):141–146. doi: 10.1097/BCR.0b013e31815f3865

[20] Cartotto R., Mayich M., Nickerson D., Gomez M. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center // J Burn Care Res. 2008. Vol. 29, N 1. Р. 141–146. doi: 10.1097/BCR.0b013e31815f3865

RIGHTS & PERMISSIONS

Eco-vector